NCT05981742View on ClinicalTrials.gov

Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin Hydrochloride 500 MG

Brand name: (Glucophage) Tablets per oral / Twice daily / 90 days duration

DRUG

Cabergoline 0.5 MG

Brand name: (Pergoline) Tablets per oral / single dose per week / 90 days duration

DRUG

Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG

"Metformin Brand name: (Glucophage) Tablets per oral / Twice daily / 90 days duration~Cabergoline Brand name: (Pergoline) Tablets per oral / single dose per week / 90 days duration"

Trial Locations (1)

58001

Maternity and Pediatric Teaching Hospital, Al Qādisīyah

All Listed Sponsors
lead

Al-Rasheed University College

OTHER